approval
saveNALBUPHINE HYDROCHLORIDE — FDA approval
community read0 votes
Sponsor: RISING. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 8
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
- approvalNALBUPHINE HYDROCHLORIDE — FDA approvalDec 22, 2025 · 283d ago
same company · ±60 days · 5
- approvalNALBUPHINE HYDROCHLORIDE: NALBUPHINE HYDROCHLORIDE — FDA approvalOct 10, 2019
- approvalBUTORPHANOL TARTRATE: BUTORPHANOL TARTRATE — FDA approvalOct 8, 2019
- approvalalfentanil hydrochloride: ALFENTA (ALFENTANIL HYDROCHLORIDE) — FDA approvalOct 7, 2019
- approvalsufentanil citrate: SUFENTA PRESERVATIVE FREE (SUFENTANIL CITRATE) — FDA approvalOct 7, 2019
- approvalEffentora: SUBLIMAZE PRESERVATIVE FREE (FENTANYL CITRATE) — FDA approvalOct 7, 2019
comments(0)
5-min edit window · permanent after that